{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:17:42Z","timestamp":1773875862249,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bbadis.2023.166801","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T01:16:40Z","timestamp":1688606200000},"page":"166801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Melanoma cells with acquired resistance to vemurafenib have decreased autophagic flux and display enhanced ability to transfer resistance"],"prefix":"10.1016","volume":"1869","author":[{"given":"Celia N.","family":"P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian R.","family":"Falc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johinna Delgado","family":"Mons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico Cuello","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Sangiacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Fernandez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula G.","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda I.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe C.M..","family":"Zoppino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio E.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166801_bb0005","first-page":"9","author":"Saginala","year":"2021","journal-title":"Epidemiology of Melanoma. Medical Sciences"},{"key":"10.1016\/j.bbadis.2023.166801_bb0010","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.2147\/OTT.S182721","article-title":"Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma","volume":"11","author":"Kakadia","year":"2018","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bbadis.2023.166801_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102801","article-title":"Mechanisms of acquired BRAF inhibitor resistance in melanoma: a systematic review","volume":"12","author":"Proietti","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2023.166801_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21037\/atm.2016.06.07","article-title":"Resistant mechanisms to BRAF inhibitors in melanoma","volume":"4","author":"Manzano","year":"2016","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.bbadis.2023.166801_bb0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1056\/NEJMe1111636","article-title":"RAF around the edges--the paradox of BRAF inhibitors","volume":"366","author":"Weeraratna","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2023.166801_bb0030","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2013.32","article-title":"Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas","volume":"133","author":"Liu","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.bbadis.2023.166801_bb0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma","volume":"508","author":"Sun","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2023.166801_bb0040","doi-asserted-by":"crossref","first-page":"E536","DOI":"10.1073\/pnas.1418163112","article-title":"BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model","volume":"112","author":"Perna","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166801_bb0045","doi-asserted-by":"crossref","unstructured":"Gerosa, L.; Chidley, C.; Frohlich, F.; Sanchez, G.; Lim, S.K.; Muhlich, J.; Chen, J.Y.; Vallabhaneni, S.; Baker, G.J.; Schapiro, D., et al. Receptor-driven ERK pulses reconfigure MAPK signaling and enable persistence of drug-adapted BRAF-mutant melanoma cells. Cell systems 2020, 11, 478-494 e479, doi:https:\/\/doi.org\/10.1016\/j.cels.2020.10.002.","DOI":"10.1016\/j.cels.2020.10.002"},{"key":"10.1016\/j.bbadis.2023.166801_bb0050","doi-asserted-by":"crossref","unstructured":"Marin-Bejar, O.; Rogiers, A.; Dewaele, M.; Femel, J.; Karras, P.; Pozniak, J.; Bervoets, G.; Van Raemdonck, N.; Pedri, D.; Swings, T., et al. Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma. Cancer Cell 2021, 39, 1135-1149 e1138, doi:https:\/\/doi.org\/10.1016\/j.ccell.2021.05.015.","DOI":"10.1016\/j.ccell.2021.05.015"},{"key":"10.1016\/j.bbadis.2023.166801_bb0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/2159-8290.CD-12-0386","article-title":"Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma","volume":"3","author":"Girotti","year":"2013","journal-title":"Cancer discovery"},{"key":"10.1016\/j.bbadis.2023.166801_bb0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature17392","article-title":"sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance","volume":"532","author":"Kaur","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2023.166801_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102870","article-title":"Tumor microenvironment: implications in melanoma resistance to targeted therapy and immunotherapy","volume":"12","author":"Falcone","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2023.166801_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2023.166801_bb0075","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s43018-021-00221-9","article-title":"Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma","volume":"2","author":"Haas","year":"2021","journal-title":"Nature cancer"},{"key":"10.1016\/j.bbadis.2023.166801_bb0080","article-title":"PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas","author":"Shen","year":"2021","journal-title":"Cancer biology & medicine"},{"key":"10.1016\/j.bbadis.2023.166801_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer discovery"},{"key":"10.1016\/j.bbadis.2023.166801_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells9091967","article-title":"New insights into the role of sphingolipid metabolism in melanoma","volume":"9","author":"Carrie","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2023.166801_bb0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fonc.2016.00218","article-title":"Sphingosine-1 phosphate: a new modulator of immune plasticity in the tumor microenvironment","volume":"6","author":"Rodriguez","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2023.166801_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11523-018-0565-2","article-title":"The role of autophagy in the resistance to BRAF inhibition in BRAF-mutated melanoma","volume":"13","author":"Liu","year":"2018","journal-title":"Target. Oncol."},{"key":"10.1016\/j.bbadis.2023.166801_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102043","article-title":"The role of autophagy in resistance to targeted therapies","volume":"88","author":"Mele","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbadis.2023.166801_bb0110","doi-asserted-by":"crossref","unstructured":"Levy, J.M.M.; Towers, C.G.; Thorburn, A. Targeting autophagy in cancer. Nat. Rev. Cancer 2017, 17, 528\u2013542, doi:nrc.2017.53 [pii] 10.1038\/nrc.2017.53.","DOI":"10.1038\/nrc.2017.53"},{"key":"10.1016\/j.bbadis.2023.166801_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010234","article-title":"Secretory autophagy forges a therapy resistant microenvironment in melanoma","volume":"14","author":"Bustos","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2023.166801_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072576","article-title":"Lysosomal exocytosis, exosome release and secretory autophagy: the autophagic- and endo-lysosomal systems go extracellular","volume":"21","author":"Buratta","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2023.166801_bb0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12079-019-00524-8","article-title":"Exosomes and autophagy: rekindling the vesicular waste hypothesis","volume":"13","author":"Gudbergsson","year":"2019","journal-title":"Journal of Cell Communication and Signaling"},{"key":"10.1016\/j.bbadis.2023.166801_bb0130","doi-asserted-by":"crossref","unstructured":"Dummer, R.; Ascierto, P.A.; Nathan, P.; Robert, C.; Schadendorf, D. Rationale for immune checkpoint inhibitors plus targeted therapy in metastatic melanoma: a review. JAMA oncology 2020, 10.1001\/jamaoncol.2020.4401, doi:10.1001\/jamaoncol.2020.4401.","DOI":"10.1001\/jamaoncol.2020.4401"},{"key":"10.1016\/j.bbadis.2023.166801_bb0135","article-title":"Hydroxynaphthalenecarboxamides and substituted piperazinylpropandiols, two new series of BRAF inhibitors. A theoretical and experimental study","volume":"103, 104145","author":"Campos","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbadis.2023.166801_bb0140","doi-asserted-by":"crossref","unstructured":"Campos, L.E.; Garibotto, F.M.; Angelina, E.; Kos, J.; Tomasic, T.; Zidar, N.; Kikelj, D.; Gonec, T.; Marvanova, P.; Mokry, P., et al. Searching new structural scaffolds for BRAF inhibitors. An integrative study using theoretical and experimental techniques. Bioorg. Chem. 2019, 91, 103125, doi:S0045-2068(19)30532-2 [pii] https:\/\/doi.org\/10.1016\/j.bioorg.2019.103125.","DOI":"10.1016\/j.bioorg.2019.103125"},{"key":"10.1016\/j.bbadis.2023.166801_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.37349\/etat.2022.00068","article-title":"Bcl-2-like protein-10 increases aggressive features of melanoma cells","volume":"3","author":"Del Bufalo","year":"2022","journal-title":"Exploration of Targeted Anti-Tumor Therapy"},{"key":"10.1016\/j.bbadis.2023.166801_bb0150","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/MCB.00554-15","article-title":"Filamin a expression negatively regulates sphingosine-1-phosphate-induced NF-kappaB activation in melanoma cells by inhibition of Akt signaling","volume":"36","author":"Campos","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2023.166801_bb0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/7651_2017_51","article-title":"In vitro methods to study the modulation of migration and invasion by sphingosine-1-phosphate","volume":"1697","author":"Castro","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2023.166801_bb0160","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1128\/MCB.00465-08","article-title":"Filamin A links sphingosine kinase 1 and sphingosine-1-phosphate receptor 1 at lamellipodia to orchestrate cell migration","volume":"28","author":"Maceyka","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2023.166801_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9112469","article-title":"Tumor necrosis factor receptor-1 (p55) deficiency attenuates tumor growth and Intratumoral angiogenesis and stimulates CD8+T cell function in melanoma","volume":"9","author":"Rodriguez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2023.166801_bb0170","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature09128","article-title":"Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2","volume":"465","author":"Alvarez","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2023.166801_bb0175","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2023.166801_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkp045","article-title":"Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data","volume":"37","author":"Ruijter","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2023.166801_bb0185","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2023.166801_bb0190","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbadis.2023.166801_bb0195","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Research"},{"key":"10.1016\/j.bbadis.2023.166801_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2023.166801_bb0205","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/bioinformatics\/btf877","article-title":"Identifying differentially expressed genes using false discovery rate controlling procedures","volume":"19","author":"Reiner","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2023.166801_bb0210","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2023.166801_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2023.166801_bb0220","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/Bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2023.166801_bb0225","first-page":"14","author":"Ng","year":"2022","journal-title":"Heterogeneity in Melanoma. Cancers"},{"key":"10.1016\/j.bbadis.2023.166801_bb0230","article-title":"Characterization of isoenzyme-selective inhibitors of human sphingosine kinases","volume":"7","author":"Gao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166801_bb0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.acr.2018.04.008","article-title":"Sphingolipids as regulators of autophagy and endocytic trafficking","volume":"140","author":"Young","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbadis.2023.166801_bb0240","first-page":"9719","article-title":"Activation of the SphK1\/ERK\/p-ERK pathway promotes autophagy in colon cancer cells","volume":"15","author":"Xu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2023.166801_bb0245","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1002\/cam4.4129","article-title":"SphK1-driven autophagy potentiates focal adhesion paxillin-mediated metastasis in colorectal cancer","volume":"10","author":"Wu","year":"2021","journal-title":"Cancer Medicine"},{"key":"10.1016\/j.bbadis.2023.166801_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2020.105610","article-title":"RNA sequencing data of vemurafenib-resistant melanoma cells and parental cells","volume":"30","author":"Zhao","year":"2020","journal-title":"Data in brief"},{"key":"10.1016\/j.bbadis.2023.166801_bb0255","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"Nazarian","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2023.166801_bb0260","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.celrep.2015.04.049","article-title":"Downregulation of the ubiquitin ligase RNF125 underlies resistance of melanoma cells to BRAF inhibitors via JAK1 deregulation","volume":"11","author":"Kim","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2023.166801_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010113","article-title":"Characterization of melanoma cell lines resistant to vemurafenib and evaluation of their responsiveness to EGFR- and MET-inhibitor treatment","volume":"21","author":"Dratkiewicz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2023.166801_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061483","article-title":"Targeting the ERK signaling pathway in melanoma","volume":"20","author":"Savoia","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2023.166801_bb0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1479-5876-8-39","article-title":"Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032","volume":"8","author":"Sondergaard","year":"2010","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbadis.2023.166801_bb0280","doi-asserted-by":"crossref","first-page":"15473","DOI":"10.1038\/s41598-021-94941-8","article-title":"Rapid signaling reactivation after targeted BRAF inhibition predicts the proliferation of individual melanoma cells from an isogenic population","volume":"11","author":"Khoshkenar","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2023.166801_bb0285","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.neo.2017.07.002","article-title":"Intercellular resistance to BRAF inhibition can be mediated by extracellular vesicle-associated PDGFRbeta","volume":"19","author":"Vella","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbadis.2023.166801_bb0290","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature14336","article-title":"Therapy-induced tumour secretomes promote resistance and tumour progression","volume":"520","author":"Obenauf","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2023.166801_bb0295","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/1535-7163.MCT-14-0701","article-title":"Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic concepts","volume":"14","author":"Paulitschke","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2023.166801_bb0300","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201695874","article-title":"Proteomic identification of a marker signature for MAPKi resistance in melanoma","volume":"38","author":"Paulitschke","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2023.166801_bb0305","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3892\/or.2017.5963","article-title":"Phenotype characterization of human melanoma cells resistant to dabrafenib","volume":"38","author":"Cordaro","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2023.166801_bb0310","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/15548627.2017.1332550","article-title":"An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAF(V600E) inhibitor-resistant metastatic melanoma cells","volume":"13","author":"Martin","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2023.166801_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179910","article-title":"Characterization of vemurafenib-resistant melanoma cell lines reveals novel hallmarks of targeted therapy resistance","volume":"23","author":"Radic","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2023.166801_bb0320","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2741\/s534","article-title":"Sorafenib induces synergistic effect on inhibition of vemurafenib resistant melanoma growth","volume":"11","author":"Srivastava","year":"2019","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbadis.2023.166801_bb0325","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1535-7163.MCT-17-1141","article-title":"Targeting the sphingosine 1-phosphate axis exerts potent antitumor activity in BRAFi-resistant melanomas","volume":"18","author":"Garandeau","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2023.166801_bb0330","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ebiom.2019.09.023","article-title":"Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma","volume":"48","author":"Smalley","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbadis.2023.166801_bb0335","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1158\/1078-0432.CCR-10-2372","article-title":"Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma","volume":"17","author":"Ma","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2023.166801_bb0340","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1172\/JCI70454","article-title":"Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma","volume":"124","author":"Ma","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2023.166801_bb0345","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/s41467-019-09634-8","article-title":"Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2023.166801_bb0350","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/exd.12298","article-title":"Dynamic interplay between autophagic flux and Akt during melanoma progression in vitro","volume":"23","author":"Maes","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbadis.2023.166801_bb0355","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.4161\/auto.21858","article-title":"ATP is released from autophagic vesicles to the extracellular space in a VAMP7-dependent manner","volume":"8","author":"Fader","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2023.166801_bb0360","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1002\/ijc.32064","article-title":"RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes","volume":"144","author":"Guo","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2023.166801_bb0365","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202110151","article-title":"Secretory autophagy maintains proteostasis upon lysosome inhibition","volume":"221","author":"Solvik","year":"2022","journal-title":"J. Cell Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923001679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923001679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T05:39:58Z","timestamp":1727761198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923001679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0925443923001679"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166801","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma cells with acquired resistance to vemurafenib have decreased autophagic flux and display enhanced ability to transfer resistance","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166801"}}